Karen Davis‐Bruno

745 total citations
19 papers, 545 citations indexed

About

Karen Davis‐Bruno is a scholar working on Pediatrics, Perinatology and Child Health, Molecular Biology and Cancer Research. According to data from OpenAlex, Karen Davis‐Bruno has authored 19 papers receiving a total of 545 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Pediatrics, Perinatology and Child Health, 6 papers in Molecular Biology and 6 papers in Cancer Research. Recurrent topics in Karen Davis‐Bruno's work include Carcinogens and Genotoxicity Assessment (6 papers), Animal testing and alternatives (5 papers) and Pharmaceutical studies and practices (5 papers). Karen Davis‐Bruno is often cited by papers focused on Carcinogens and Genotoxicity Assessment (6 papers), Animal testing and alternatives (5 papers) and Pharmaceutical studies and practices (5 papers). Karen Davis‐Bruno collaborates with scholars based in United States, Switzerland and Belgium. Karen Davis‐Bruno's co-authors include Melissa S. Tassinari, Aisar Atrakchi, Graham P. Allaway, Marie‐Claire Gauduin, J. Steven McDougal, Karl W. Hasel, Richard A. Koup, Paul J. Maddon, Gary A. Beaudry and P. V. Halushka and has published in prestigious journals such as SHILAP Revista de lepidopterología, Biochemical Pharmacology and Chemical Research in Toxicology.

In The Last Decade

Karen Davis‐Bruno

17 papers receiving 529 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Karen Davis‐Bruno United States 12 180 149 132 108 77 19 545
Jiayin Qiu China 13 73 0.4× 180 1.2× 77 0.6× 294 2.7× 19 0.2× 32 731
Erik Pacyniak United States 16 330 1.8× 139 0.9× 107 0.8× 158 1.5× 19 0.2× 23 600
Dale M. Walker United States 18 128 0.7× 275 1.8× 23 0.2× 209 1.9× 37 0.5× 37 771
Yun Lan Yueh United States 8 108 0.6× 62 0.4× 106 0.8× 144 1.3× 32 0.4× 10 384
Angela D. Myracle United States 12 169 0.9× 207 1.4× 204 1.5× 81 0.8× 22 0.3× 18 636
Nelly Buron France 14 34 0.2× 182 1.2× 48 0.4× 28 0.3× 17 0.2× 19 526
Marleen C.D.G. Huigen Netherlands 12 145 0.8× 256 1.7× 53 0.4× 95 0.9× 78 1.0× 22 511
Vladimir T. Valuev-Elliston Russia 13 107 0.6× 285 1.9× 80 0.6× 174 1.6× 9 0.1× 40 764
Paula E. Scarborough United States 11 177 1.0× 315 2.1× 86 0.7× 191 1.8× 3 0.0× 15 877
Michelle Skelton South Africa 13 73 0.4× 202 1.4× 27 0.2× 120 1.1× 24 0.3× 33 638

Countries citing papers authored by Karen Davis‐Bruno

Since Specialization
Citations

This map shows the geographic impact of Karen Davis‐Bruno's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Karen Davis‐Bruno with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Karen Davis‐Bruno more than expected).

Fields of papers citing papers by Karen Davis‐Bruno

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Karen Davis‐Bruno. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Karen Davis‐Bruno. The network helps show where Karen Davis‐Bruno may publish in the future.

Co-authorship network of co-authors of Karen Davis‐Bruno

This figure shows the co-authorship network connecting the top 25 collaborators of Karen Davis‐Bruno. A scholar is included among the top collaborators of Karen Davis‐Bruno based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Karen Davis‐Bruno. Karen Davis‐Bruno is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Yao, Jia, Jackye Peretz, Bo Ram Lee, et al.. (2025). FDA/CDER/OND Experience With New Approach Methodologies (NAMs). International Journal of Toxicology. 45(2). 136–156.
2.
Guo, Xiaoqing, Robert T. Dorsam, Aisar Atrakchi, et al.. (2024). Mutagenicity and genotoxicity evaluation of 15 nitrosamine drug substance-related impurities in human TK6 cells. Regulatory Toxicology and Pharmacology. 154. 105730–105730. 9 indexed citations
3.
Li, Xilin, Ji‐Eun Seo, Xiaoqing Guo, et al.. (2023). Revisiting the mutagenicity and genotoxicity of N-nitroso propranolol in bacterial and human in vitro assays. Regulatory Toxicology and Pharmacology. 141. 105410–105410. 23 indexed citations
4.
He, Xiaobo, Xiaoqing Guo, Matthew Bryant, et al.. (2022). Genotoxicity evaluation of nitrosamine impurities using human TK6 cells transduced with cytochrome P450s. Archives of Toxicology. 96(11). 3077–3089. 19 indexed citations
5.
Campion, Sarah N., Amy L. Inselman, Costanza Casiraghi, et al.. (2022). The benefits, limitations and opportunities of preclinical models for neonatal drug development. Disease Models & Mechanisms. 15(4). 5 indexed citations
6.
Gordon, John, Matthew Johnson, Emily N. Reinke, et al.. (2021). Measuring U.S. Federal Agency progress toward implementation of alternative methods in toxicity testing. 2 indexed citations
7.
Wange, Ronald L., Paul C. Brown, & Karen Davis‐Bruno. (2021). Implementation of the principles of the 3Rs of animal testing at CDER: Past, present and future. Regulatory Toxicology and Pharmacology. 123. 104953–104953. 28 indexed citations
8.
Aungst, Jason, Federica Basso, Karen Davis‐Bruno, et al.. (2018). Utility of generational developmental and reproductive toxicity and juvenile animal study protocols for the infant safety assessment of food contact materials. SHILAP Revista de lepidopterología. 2.
9.
Davis‐Bruno, Karen, Luc De Schaepdrijver, Pieter Annaert, et al.. (2016). Nonclinical Models for Neonatal Pediatric Drug Development. Reproductive Toxicology. 64. 49–49. 1 indexed citations
10.
Davis‐Bruno, Karen & Melissa S. Tassinari. (2011). Essential fatty acid supplementation of DHA and ARA and effects on neurodevelopment across animal species: a review of the literature. Birth Defects Research Part B Developmental and Reproductive Toxicology. 92(3). 240–250. 57 indexed citations
11.
Tassinari, Melissa S., Kimberly Benson, Ikram Elayan, Parvaneh Espandiari, & Karen Davis‐Bruno. (2011). Juvenile animal studies and pediatric drug development retrospective review: use in regulatory decisions and labeling. Birth Defects Research Part B Developmental and Reproductive Toxicology. 92(4). n/a–n/a. 20 indexed citations
12.
Leconte, Isabelle, Graham P. Bailey, Karen Davis‐Bruno, et al.. (2011). Value of juvenile animal studies. Birth Defects Research Part B Developmental and Reproductive Toxicology. 92(4). 292–303. 15 indexed citations
13.
Beyer, Bruce, Neil Chernoff, Bengt Danielsson, et al.. (2010). ILSI/HESI maternal toxicity workshop summary: maternal toxicity and its impact on study design and data interpretation. Birth Defects Research Part B Developmental and Reproductive Toxicology. 92(1). 36–51. 45 indexed citations
14.
Buckley, Lorrene A., Karen Davis‐Bruno, Gregory L. Finch, et al.. (2008). Nonclinical Aspects of Biopharmaceutical Development: Discussion of Case Studies at a PhRMA-FDA Workshop. International Journal of Toxicology. 27(4). 303–312. 12 indexed citations
15.
Davis‐Bruno, Karen & Aisar Atrakchi. (2006). A Regulatory Perspective on Issues and Approaches in Characterizing Human Metabolites. Chemical Research in Toxicology. 19(12). 1561–1563. 46 indexed citations
16.
Hurtt, Mark E., G. P. Daston, Karen Davis‐Bruno, et al.. (2004). Juvenile animal studies: Testing strategies and design. Birth Defects Research Part B Developmental and Reproductive Toxicology. 71(4). 281–288. 13 indexed citations
17.
Halushka, P. V., et al.. (1995). Thromboxane A2 receptors. PubMed. 12(2-3). 361–378. 45 indexed citations
18.
Schrör, Karsten, Karen Davis‐Bruno, & P. V. Halushka. (1995). Inhibition of ligand binding to thromboxane A2/prostaglandin H2 receptors by diethylpyrocarbonate. Biochemical Pharmacology. 49(7). 921–927. 7 indexed citations
19.
Allaway, Graham P., Karen Davis‐Bruno, Gary A. Beaudry, et al.. (1995). Expression and Characterization of CD4-IgG 2 , a Novel Heterotetramer That Neutralizes Primary HIV Type 1 Isolates. AIDS Research and Human Retroviruses. 11(5). 533–539. 198 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jiayin Qiu Breakdown of academic impact, for papers by Erik Pacyniak Breakdown of academic impact, for papers by Dale M. Walker Breakdown of academic impact, for papers by Yun Lan Yueh Breakdown of academic impact, for papers by Angela D. Myracle Breakdown of academic impact, for papers by Nelly Buron Breakdown of academic impact, for papers by Marleen C.D.G. Huigen Breakdown of academic impact, for papers by Vladimir T. Valuev-Elliston Breakdown of academic impact, for papers by Paula E. Scarborough Breakdown of academic impact, for papers by Michelle Skelton
Rankless by CCL
2026